Magnesium Sulfate as Adjuvant in Prehospital Femoral Nerve Block for a Patient with Diaphysial Femoral Fracture: A Randomized Controlled Trial

Chawki Jebali, Mohamed Kahloul, Nesrine Ibn Hassine, Mohamed Aymen Jaouadi, Fehmi Ferhi, Walid Naija, Naoufel Chebili, Chawki Jebali, Mohamed Kahloul, Nesrine Ibn Hassine, Mohamed Aymen Jaouadi, Fehmi Ferhi, Walid Naija, Naoufel Chebili

Abstract

Introduction: Prehospital management of traumatic pain is commonly based on morphine while locoregional analgesia techniques, especially the femoral nerve block (FNB), can be safely and efficiently used. Adjuvants uses can reduce local anesthetic doses and decrease their related risk. The aim of the study was to assess the analgesic effect of magnesium sulfate when used as an adjuvant in prehospital FNB.

Methods: This is a randomized double-blinded trial conducted in a prehospital medical department of an academic hospital. Patients with isolated diaphysial femoral fracture and eligible to participate were randomized into 2 groups. Group C had a FNB with 15 ml of lidocaine with epinephrine (300 mg) and 3 ml of normal saline solution. Group I had a FNB with 15 ml of lidocaine with epinephrine (300 mg) and 3 ml of MgS 15% (450 mg). The FNB was performed according to the WINNIE technique. Primary endpoints were morphine consumption and pain intensity during the first 6 hours. Secondary endpoints were the duration of the sensory block, time to the first analgesic request, and side effects occurrence.

Results: Twenty-four patients were enrolled in each group. Both groups were comparable according to demographic characteristics, initial pain scores, and vital constants. In group I, morphine requirements were significantly lower (2 ± 2 mg versus 5 ± 3 mg, p < 10-3), analgesic onset was significantly faster, and the average time to the first analgesic request was longer (276 ± 139 min versus 160 ± 79 min, p < 10-3). The average duration of sensory block was longer in group I (226 ± 64 min versus 116 ± 70 min p < 10-3). No side effects were recorded.

Conclusion: Magnesium sulfate should be considered as an efficient and safe adjuvant to lidocaine in prehospital FNB. This trial is registered with (NCT03597945).

Figures

Figure 1
Figure 1
Flowchart of clinical trial.
Figure 2
Figure 2
Morphine requirements in each group of the study.
Figure 3
Figure 3
Evolution of pain intensity in both groups.

References

    1. Violeau M., Lefort H., Mimoz O., et al. Evaluation of locoregional anesthesia procedure in the emergency and prehospital care by the emergency of a French county. Anesth Reanim. 2015;1(3):232–237.
    1. Dupré L. J. Bloc “3 en 1” ou bloc femoral. Que faut-il faire et comment le faire? Annales Françaises d’Anesthèsie et de Rèanimation. 1996;15:1099–1106.
    1. Capdevila X., Biboulet P., Bouregba M., Rubenovitch J., Jaber S. Bilateral continuous 3-in-1 nerve blockade for postoperative pain relief after bilateral femoral shaft surgery. Journal of Clinical Anesthesia. 1998;10(7):606–609. doi: 10.1016/s0952-8180(98)00097-x.
    1. Schiferer A., Gore C., Gorove L., et al. A randomized controlled trial of femoral nerve blockade administered preclinically for pain relief in femoral trauma. Anesthesia & Analgesia. 2007;105(6):1852–1854. doi: 10.1213/01.ane.0000287676.39323.9e.
    1. Taha A. M., Abd-Elmaksoud A. M. Lidocaine use in ultrasound guided femoral nerve block: what is the minimum effective anaesthetic concentration (MEAC90)? British Journal of Anaesthesia. 2013;110(6):1040–1044. doi: 10.1093/bja/aes595.
    1. Fawcet W. J., Haxby E. J., Male D. A. Magnesium: physiology and pharmacology. British Journal of Anaesthesia. 1999;83(2):302–320. doi: 10.1093/bja/83.2.302.
    1. Woolf C. J., Thompson S. W. N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain and hypersensitivity states. Pain. 1991;44(3):293–299. doi: 10.1016/0304-3959(91)90100-c.
    1. Koinig H., Wallner T., Marhofer P., Andel H., Hörauf K., Mayer N. Magnesium sulphate reduces intra and postoperative analgesic requirement. Anesthesia & Analgesia. 1998;87(1):206–210. doi: 10.1097/00000539-199807000-00042.
    1. Ozcan P. E., Tugrul S., Senturk N. M., et al. Role of magnesium sulphate in postoperative pain management for patients undergoing thoracotomy. Journal of Cardiothoracic and Vascular Anesthesia. 2007;21(6):827–831. doi: 10.1053/j.jvca.2006.11.013.
    1. Sirvinskas E., Laurinaitis R. Use of magnesium sulphate in anesthesiology. Medicina. 2002;38(7):695–698.
    1. Tramer M. R., Schneider J., Marti R. A., Rifat K. Role of Magnesium sulphate in postoperative analgesia. Anesthesiology. 1996;8(2):340–347. doi: 10.1097/00000542-199602000-00011.
    1. Levaux C., Bonhomme V., Dewandre P. Y., Brichant J. F., Hans P. Effect of intra-operative magnesium sulphate on pain relief and patient comfort after major lumbar orthopedic surgery. Anesthesia. 2003;58(2):131–135. doi: 10.1046/j.1365-2044.2003.02999.x.
    1. Koo B. N., Kil H. K., Shin Y. S., Song J. W., Hong Y. W. The clinical effects of intrathecal MgSO4 on spinal anesthesia and postoperative epidural analgesia in total knee replacement. Regional Anesthesia and Pain Medicine. 2004;29:11–13. doi: 10.1016/j.rapm.2004.07.112.
    1. ELShamaa H. A., Ibrahim M., Eldesuky H. L. Magnesium sulfate in femoral nerve block, does postoperative analgesia differ? A comparative study. Egyptian Journal of Anaesthesia. 2014;30(2):169–173. doi: 10.1016/j.egja.2013.10.005.
    1. Boccard E., Adnet F., Gueugniaud P. Y., Filipovics A., Ricard-Hibon A. Pain management in adult patients in emergency care units in France in 2010. Annales Françaises de Médecine d’Urgence. 2011;1:312–319.
    1. Bondok R. S., Abd El-Hady A. M. Intra-articular magnesium is effective for postoperative analgesia in arthroscopic knee surgery. British Journal of Anaesthesia. 2006;97(3):389–392. doi: 10.1093/bja/ael176.
    1. Kashefi P., Montazeri K., Honarmand A., Masoomi G. Adding magnesium sulphate to lidocaine for intravenous regional anesthesia. Regional Anesthesia and Pain Medicine. 2008;33(1):p. e97. doi: 10.1097/00115550-200809001-00185.
    1. Hassan M. E., Mahran E. Effect of adding magnesium sulphate to bupivacaine on the clinical profile. Egyptian Journal of Anaesthesia. 2015;31(1):23–27. doi: 10.1016/j.egja.2014.11.003.
    1. James M. F. Clinical use of magnesium infusions in anesthesia. Anesthesia & Analgesia. 1992;74(1):129–137. doi: 10.1213/00000539-199201000-00021.
    1. Hwang J. Y., Na H. S., Jeon Y. T., Ro Y. J., Kim C. S., Do S. H. I.V. Infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia. British Journal of Anaesthesia. 2010;104(1):89–93. doi: 10.1093/bja/aep334.
    1. Akutagawa T., Kitahata L. M., Saito H., Collins J. G., Katz J. D. Magnesium enhances local anesthetic nerve block of frog Sciatic nerve. Anesthesia & Analgesia. 1984;63(2):111–116. doi: 10.1213/00000539-198402000-00004.
    1. Dickenson A. H. NMDA receptor antagonists as analgesics. In: Fields H. L., Liebeskind J. C., editors. Progress in Pain Research and Management. Seattle, WA, USA: IASP Press; 1994. pp. 73–87.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi